Drag a card by its title · ⚙ to size, swap or remove

The company

EyePoint, Inc.

EYPT · Nasdaq

Health CareBiotechnologyNot moving yet

EYPT stood above a rising 150-day average in 21 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 95.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 26
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $144K
Insider sales, 12 months: $3.0M
Officials’ trades on record: 0
Institutions holding: 181 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 21 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2

Sale orders, 12 months10

Buyers · sellers2 · 3

Who	Did	Shares	Traded
Karen L. ZaderejDirector	bought	10,600at $4.93	18 Aug 2026filed 18 Aug 2026
Ramiro RibeiroChief Medical Officer	sold	2,437at $15.00	30 Jun 2026filed 2 Jul 2026
Ramiro RibeiroChief Medical Officer	sold	2,438at $15.02	30 Jun 2026filed 2 Jul 2026
Ramiro RibeiroChief Medical Officer	sold	2,437at $15.00	17 Apr 2026filed 20 Apr 2026
Jay S. DukerPresident and CEO	bought	1,500at $13.15	16 Mar 2026filed 16 Mar 2026
Ramiro RibeiroChief Medical Officer	sold	2,438at $17.87	4 Mar 2026filed 5 Mar 2026
Ramiro RibeiroChief Medical Officer	sold	2,437at $15.00	17 Feb 2026filed 18 Feb 2026
Ramiro RibeiroChief Medical Officer	sold	42,544at $17.10	5 Jan 2026filed 7 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders181+0 on the quarter

New · exited24 · 24

Reported value$1.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 2026	8,296,375$118.6M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	7,463,197$106.7M	+285,860+4.0%
Cormorant Asset Management, LPreduced · filed 14 Aug 2026	7,000,000$100.1M	-1,265,000−15.3%
FEDERATED HERMES, INC.added · filed 12 Aug 2026	5,681,052$81.2M	+11,463+0.2%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	4,827,792$69.0M	+1,527,792+46.3%
FRANKLIN RESOURCES INCreduced · filed 13 Aug 2026	4,807,078$68.7M	-241,520−4.8%
Commodore Capital LPadded · filed 14 Aug 2026	4,600,000$65.8M	+1,775,000+62.8%
Jupiter Topco LLCnew · filed 14 Aug 2026	3,770,381$53.9M	+3,770,381
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,630,252$51.9M	+70,683+2.0%
Paradigm Biocapital Advisors LPreduced · filed 14 Aug 2026	2,890,397$41.3M	-252,040−8.0%